Compounds > aminoimidazole carboxamide
Page last updated: 2024-08-21

aminoimidazole carboxamide and Hyperlipidemias

aminoimidazole carboxamide has been researched along with Hyperlipidemias in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dong, H; Jiang, SJ; Li, JB; Lu, FE; Wang, KF; Xu, LJ; Yi, P; Zou, X1
Cooney, J; Ewart, MA; Greig, FH; Kennedy, S; McNaughton, E; Spickett, CM1
Fiedler, M; Liang, Y; Sakariassen, KS; Selén, G; Wallberg-Henriksson, H; Zierath, JR1

Other Studies

3 other study(ies) available for aminoimidazole carboxamide and Hyperlipidemias

ArticleYear
Berberine inhibits hepatic gluconeogenesis via the LKB1-AMPK-TORC2 signaling pathway in streptozotocin-induced diabetic rats.
    World journal of gastroenterology, 2015, Jul-07, Volume: 21, Issue:25

    Topics: Active Transport, Cell Nucleus; Aminoimidazole Carboxamide; AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Animals; Berberine; Biomarkers; Blood Glucose; Diabetes Mellitus, Experimental; Gluconeogenesis; Glucose-6-Phosphatase; Hyperlipidemias; Hypoglycemic Agents; Insulin; Insulin Resistance; Intracellular Signaling Peptides and Proteins; Lipids; Liver; Male; Metformin; Phosphoenolpyruvate Carboxykinase (GTP); Phosphorylation; Protein Serine-Threonine Kinases; Rats, Wistar; Ribonucleotides; Signal Transduction; Streptozocin; Time Factors; Trans-Activators; Up-Regulation

2015
The hypotensive effect of acute and chronic AMP-activated protein kinase activation in normal and hyperlipidemic mice.
    Vascular pharmacology, 2015, Volume: 74

    Topics: Acetyl-CoA Carboxylase; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Antihypertensive Agents; Aorta; Blood Pressure; Enzyme Activation; Hyperlipidemias; Male; Mice; Mice, Inbred C57BL; Phosphorylation; Ribonucleotides; Vasodilation

2015
5-aminoimidazole-4-carboxy-amide-1-beta-D-ribofuranoside treatment ameliorates hyperglycaemia and hyperinsulinaemia but not dyslipidaemia in KKAy-CETP mice.
    Diabetologia, 2001, Volume: 44, Issue:12

    Topics: Aminoimidazole Carboxamide; Animals; Carrier Proteins; Cholesterol Ester Transfer Proteins; Diabetes Mellitus, Type 2; Disease Models, Animal; Female; Glucose; Glycoproteins; Hyperglycemia; Hyperinsulinism; Hyperlipidemias; Hypoglycemic Agents; Mice; Mice, Transgenic; Muscle, Skeletal; Ribonucleotides

2001